Breaking News, Collaborations & Alliances

GeneFab & RegCell Partner for Treg Therapy Manufacturing in the U.S.

Will support the tech transfer and clinical manufacturing of RegCell’s Treg platform as it transitions from Japan to GeneFab's manufacturing facility in Alameda, CA.

Author Image

By: Charlie Sternberg

Associate Editor

GeneFab, a cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCell, a biotech company advancing regulatory T cell (Treg) therapies for autoimmune diseases, to support the tech transfer and clinical manufacturing of RegCell’s Treg platform as it transitions from Japan to GeneFab’s manufacturing facility in Alameda. GeneFab will provide full cohesive CRDMO support, including technology transfer, process development, ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters